The quantitative determination of gamma-hydroxybutyric acid (GHB) in urine samples is very important to assess illicit intake or administration. To this end we evaluated several analytical methods: headspace gas-chromatography coupled to flame ionization detection (HS-GC/FID), headspace gas-chromatography coupled to mass spectrometry (HS-GC/MS), headspace gas-chromatography coupled to solid phase microextraction and mass spectrometry (HS-SPME-GC/MS). All these methods were endowed with a not sufficient sensitivity, and then we moved to solid phase microextraction coupled to gas-chromatography with mass spectrometry detection (SPME-GC/MS). At first, GHB was extracted from urine with an organic solvent and analyzed after derivatization. Under these conditions, however, there was a partial overlapping between the chromatographic peak of GHB and that of urea, also extracted by the organic solvent. Then we decided to change analytical approach and to convert GHB to gamma-butyrolactone (GBL), which is not an endogenous compound. A SPME method was optimized and validated for the determination of GBL. The limit of detection (LOD) of the method resulted to be 0.25 μg/mL for GBL, corresponding to 0.5 μg/mL for GHB. The lower limit of quantification (LLOQ) was 0.4 μg/mL for GBL and 0.8 μg/mL for GHB. The LLOQ of the method resulted 10 times lower than the endogenous level, thus allowing to distinguish between physiological conditions and exogenous assumption.
|Titolo:||A Novel Approach by SPME-GC/MS for the Determination of gammahydroxybutyric acid (GHB) in Urine Samples after Conversion into gamma-butyrolactone (GBL)|
|Parole Chiave:||gamma-Hydroxybutyric acid (GHB); gamma-butyrolactone (GBL); HS-GC/FID; HS-GC/MS; HS-SPME-GC/ MS; SPME-GC/MS|
|Settore Scientifico Disciplinare:||Settore CHIM/08 - Chimica Farmaceutica|
|Data di pubblicazione:||nov-2018|
|Appare nelle tipologie:||01 - Articolo su periodico|